UP!

ACTG $3.79   View long term graphs

Type
Public
Traded as NASDAQ: ACTG
Industry Patent Licensing & Monetization
Founded 1993
Headquarters Newport Beach, California, USA
Key people
Marvin Key, CEO
Clayton J. Haynes, CFO
Subsidiaries Acacia Research Group LLC
Website acaciaresearch.com

Acacia Research Corporation is an American company based in Newport Beach, California, that works to license patents and perform relevant legal action such as dealing with patent infringement.

Acacia is sometimes referred to as a non-practicing entity because the company derives revenue from licenses and lawsuits rather than from building products. According to the company, it has returned over $705,000,000 to patent owners. The corporation creates a subsidiary company for each set of patents it enforces. Currently, 95% of the company's business involves partnering with inventors and patent holders. It currently has 180 known subsidiaries and 257 active cases as of September 2014, four of which are not through a subsidiary.

News

Acacia Research Corporation (industrials)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-10 Future report Set alerts
Q3 2020 2020-11-10 Future report Set alerts
Q2 2020 2020-08-10 -0.11 0.09
Q1 2020 2020-05-11 0.00 -0.24
Q4 2019 2020-03-12 0.00 -0.05
Q3 2019 2019-11-12 0.00 -0.15
Q2 2019 2019-08-05 0.00 -0.12
Q1 2019 2019-05-09 0.00 -0.09
Q4 2018 2019-03-13 0.00 -0.23
Q3 2018 2018-10-25 0.11 -0.67

Ratings

2016-05-23 Upgrade Northland Securities Market Perform to Outperform $5.20 to $7.00
2016-01-05 Downgrade Barclays Equal Weight to Underweight $12.00 to $4.00
2016-01-05 Downgrade Barclays PLC Equal Weight to Underweight $12.00 to $4.00
2015-12-28 Downgrade Northland Securities Hold
2015-12-23 Lower Price Target Lake Street Capital Buy $12.00 to $6.50
2015-12-22 Downgrade Northland Securities Outperform to Market Perform $5.40
2015-08-20 Lower Price Target Barclays Equal Weight $15.00 to $12.00
2015-04-23 Set Price Target Cowen and Company Outperform to Buy $20.00
2015-02-20 Lower Price Target JPMorgan Chase & Co. Overweight $17.00 to $15.00
2015-02-20 Set Price Target Barclays Hold $20.00 to $15.00
2015-02-20 Lower Price Target Cowen and Company Outperform $24.00 to $20.00
2015-01-21 Lower Price Target Northland Securities Outperform $23.00 to $17.00
2014-10-23 Reiterated Rating Barclays Equal Weight $19.00 to $20.00
2014-09-18 Initiated Northland Capital Outperform $23
2014-09-18 Initiated Coverage Northland Securities Outperform $23.00
2014-07-29 Boost Price Target Barclays Equal Weight $15.00 to $19.00
2014-07-29 Boost Price Target Robert W. Baird Equal Weight $15.00 to $19.00
2014-05-15 Reiterated Rating Cowen and Company Positive
2014-04-22 Reiterated Rating JPMorgan Chase & Co. Overweight $20.50
2014-04-21 Initiated Coverage Cantor Fitzgerald Buy
2014-04-21 Initiated Coverage Wedbush Outperform $24.00
2014-02-21 Lower Price Target Barclays Equal Weight $19.00 to $15.00
2014-02-21 Lower Price Target JPMorgan Chase & Co. $22.50 to $21.50
2014-02-20 Reiterated Rating Cowen and Company Outperform
2013-11-04 Reiterated Cowen Outperform $36 to $24
2013-11-04 Lower Price Target Cowen and Company Outperform $36.00 to $24.00
2013-10-18 Downgrade Stephens Overweight to Underweight
2013-09-17 Initiated Coverage Standpoint Research Buy $33.00
2011-07-08 Initiated Barclays Capital Equal Weight $41
2011-04-19 Initiated GARP Research Buy
2008-07-25 Downgrade Davenport Strong Buy to Buy $8
2007-04-27 Reiterated Davenport Strong Buy $20 to $24
2016-05-23 Upgrade Northland Securities Market Perform to Outperform $5.20 to $7.00
2016-01-05 Downgrade Barclays Equal Weight to Underweight $12.00 to $4.00
2016-01-05 Downgrade Barclays PLC Equal Weight to Underweight $12.00 to $4.00
2015-12-28 Downgrade Northland Securities Hold
2015-12-23 Lower Price Target Lake Street Capital Buy $12.00 to $6.50

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
RYAN PAUL R President & CEO 0.86%  (430891) ACTG /
WALSH FRANK E III 0.79%  (395726) ACTG / FCCY /
HARRIS ROBERT L II Executive Chairman 0.76%  (379609) ACTG / HPP /
GRAZIADIO G LOUIS III 0.71%  (354500) ACTG / WPT /
Vella Matthew President 0.49%  (245884) ACTG /
Key Marvin E CEO 0.38%  (190833) ACTG /
Stewart Robert B Jr President 0.20%  (98643) ACTG /
HAYNES CLAYTON J Sr.V.P, CFO 0.19%  (94667) ACTG /
DEBOOM FRED A 0.16%  (78600) ACTG /
FRYKMAN EDWARD W 0.15%  (73290) ACTG / ARWR /
Lee Dooyong Executive Vice President 0.14%  (69467) ACTG /
Treska Edward Joseph Sr. V.P., G.C., Secretary 0.11%  (56035) ACTG /
Anderson William S. 0.09%  (47370) ACTG / FCTY /

Comments